CAS 135646-98-9
:5-Heptenoic acid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxo-5-phenylpentyl)cyclopentyl]-,1-methylethyl ester, (5Z)-
Description:
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxo-5-phenylpentyl)cyclopentyl]-, 1-methylethyl ester, (5Z)-, is a complex organic compound characterized by its unique structure that includes a heptenoic acid backbone and a cyclopentyl moiety with multiple functional groups. This compound features a double bond in the heptenoic acid chain, indicating its unsaturation, which can influence its reactivity and physical properties. The presence of hydroxyl groups suggests potential for hydrogen bonding, which may enhance its solubility in polar solvents. The ester functional group indicates that it can undergo hydrolysis, making it relevant in various chemical reactions. Additionally, the phenyl group contributes to the compound's hydrophobic characteristics, potentially affecting its biological activity and interaction with other molecules. Overall, this compound's intricate structure and functional groups suggest it may have applications in fields such as pharmaceuticals, biochemistry, or materials science, although specific applications would depend on further research and characterization.
Formula:C26H38O5
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
15-keto Latanoprost
CAS:Latanoprost, a PG analog for ocular pressure, metabolizes into 15-keto latanoprost, a less potent variant reducing intraocular pressure and pupil size.Formula:C26H38O5Color and Shape:SolidMolecular weight:430.5815-Keto Latanoprost
CAS:<p>Applications 15-Keto Latanoprost is a metabolite of Latanoprost (L177280).<br>References Sjoquist, B., et al.: Drug Metab. Dispos., 26, 745 (1998), Watson, P., et al.: Drugs Today, 35, 449 (1999),<br></p>Formula:C23H30O5Color and Shape:NeatMolecular weight:386.4815-Keto latanoprost
CAS:<p>Latanoprost is a prostaglandin analogue that lowers intraocular pressure by increasing the outflow of aqueous humor from the eye. Latanoprost is an impurity, which means it is not the active ingredient. It has been found to have low levels of impurities such as chloride, benzalkonium chloride, and method development. The study drug was prepared by chromatography in acetonitrile and eluted with water. The nature of the study drug was determined with radiation and found to be a clear liquid. This compound is used for treatment of glaucoma and ophthalmic diseases.</p>Formula:C26H38O5Purity:Min. 95%Color and Shape:Colorless Clear LiquidMolecular weight:430.58 g/mol




